Investegate |Oxurion NV Announcements | Oxurion NV: OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Investegate announcements from Oxurion NV, OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Stay updated with breaking news from Karen Beets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Oxurion NV, OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Press release content from Globe Newswire. The AP news staff was not involved in its creation. OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting Oxurion NVApril 30, 2021 GMT Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies with a clinical stage portfolio in retinal vascular disorders. Oxurion NV is announcing the presentation of novel scientific data at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 20...